Found 9 matching trials
Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy PHASE4 The primary objective of this study is to evaluate the broad clinical benef...
Show More Learn More & Join Trial
Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder PHASE1 This study is to compare the pharmacokinetics of FK949E low dose tablets an...
Show More Location
Multiple Locations
Learn More & Join Trial
Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy PHASE3 Prospective, open-label, controlled (active comparator), randomized study o...
Show More Learn More & Join Trial
Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression PHASE4 In essence the researchers are hoping to test two separate hypotheses (desc...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression PHASE4 The purpose of the study is to compare the sedation profile one hour after ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder PHASE2 In this study, quetiapine XR or placebo will be administered orally for 6 w...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression PHASE3 The purpose of this study is to compare the efficacy of quetiapine fumarate...
Show More Learn More & Join Trial
Quetiapine XR in Schizophrenic Patients PHASE3 The purpose of the study is to determine the effect of Quetiapine in patien...
Show More Location
Hannover Medical School
Learn More & Join Trial
Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression PHASE3 The primary objective of this study is to evaluate the superior efficacy of...
Show More Learn More & Join Trial